AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 27 - (NewsRx.com & NewsRx.net) -- The Breast Cancer Care & Research Fund's web site, Breastlink.org, features a study of some 2755 breast cancer patients showing that women who used hormone replacement therapy (HRT) after diagnosis had significantly fewer recurrences and deaths than nonusers.
Similarly, a review of the literature on use of hormone replacement therapy by breast cancer survivors revealed no adverse effect on recurrence. However, experts urge caution.
"If a breast cancer survivor is interested in taking HRT, it should be very clear why she's interested and what alternatives there are for the problem," says Rena Sellin, MD, professor of medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Other Breastlink.org articles encompass the following topics:
* "The Risk of Breast Cancer Varies by Age and Ethnicity" - the widely publicized one-in-nine lifetime risk of developing breast cancer is misleading and causes many women to overestimate their actual risk. This population study of California women shows that risk of breast cancer varies according to a woman's current age and ethnicity. Expert commentary is provided by Joseph Costantino, PhD, associate professor of biostatistics, Graduate School of Public Health University of Pittsburgh, Pennsylvania.
* "Additional Chemotherapy Relieves Symptoms of Locally Recurrent Advanced Breast Cancer" - British researchers report that more than one course of systemic chemotherapy may be an ...
Source: HighBeam Research, Hormone Replacement Therapy May Be An Option For Some...